The medical technology firm reached a valuation exceeding $1 billion following a new investment round.
Live Poll
Do you support significant private investment in brain-computer interface technology?
September 23, 2026
Debbie Allen and Merck Launched HIV Health ProgramThe initiative aims to help people with HIV build personalized support networks for their mental and social well-being.
September 23, 2026
Researchers Identified Key Driver of Tuberous SclerosisUC Berkeley scientists found hyperreactive astrocytes contribute to lesion formation in patients with the condition.
September 23, 2026
Depression Linked to Reduced New Brain Neuron GrowthA study published August 21, 2026, revealed that depression inhibits the maturation of new hippocampal neurons.
September 23, 2026
Study Evaluated Alternative Dosing for ERZOFRIResearchers modeled new maintenance intervals for the schizophrenia drug using pharmacokinetic simulations.
September 23, 2026
Chesley Sullenberger Announced Alzheimer’s DiagnosisThe former pilot revealed his condition to advocate for early testing and improved health outcomes.
September 23, 2026
Alkermes Expanded Medical Research Grant ProgramThe company has added narcolepsy and idiopathic hypersomnia to its funding criteria for early-career researchers.
September 23, 2026
Medical Panel Backed AI Tools for Alzheimer’s TherapyExperts endorsed a framework using AI to monitor for brain swelling and bleeding during anti-amyloid treatments.
September 22, 2026
Researchers Linked Spinal Bone Density to Cognitive DeclineA study found that lower thoracic bone mineral density is associated with faster brain function degradation.
September 22, 2026
AANEM Will Preview New Myasthenia Gravis TreatmentsThe 2026 MGFA Scientific Session will highlight advancements in targeted therapies for myasthenia gravis.
September 22, 2026
Scientists Have Advanced CTE Testing for Living PatientsResearchers are developing new PET scan tracers and blood tests to identify chronic traumatic encephalopathy.
